News Breaks |
|
|
| January 15, 2013 |
| 08:04 EDT |  | QGEN | QIAGEN submits companion diagnostic to FDA for afatinib
QIAGEN announced submission of its therascreen EGFR RGQ PCR Kit to the FDA as a proposed companion diagnostic to guide treatment with afatinib, a new investigational oncology compound developed by Boehringer Ingelheim. Afatinib has been accepted for filing and granted Priority Review by the FDA as a proposed treatment for patients with locally advanced or metastatic non-small cell lung cancer who havewith an epidermal growth factor receptor mutation detected by an FDA-approved test. |
|
|
News For QGEN From The Last 14 Days Check below for free stories on QGEN the last two weeks. |
|
|
| There are no results for QGEN |
|
|
|
|
